Clinical Trials Logo

Hemangioma clinical trials

View clinical trials related to Hemangioma.

Filter by:

NCT ID: NCT00312520 Completed - Hemangiomas Clinical Trials

Pulse Steroids Versus Oral Steroids in Problematic Hemangiomas of Infancy

Start date: July 2002
Phase: Phase 3
Study type: Interventional

The purpose of the study is to determine if pulse steroids are more efficacious and safer than the standard treatment with oral corticosteroids.

NCT ID: NCT00243893 Completed - Clinical trials for Arteriovenous Malformations

Tetracycline-Derivatives for Treatment of Cerebral Arteriovenous Malformations and Aneurysms

Start date: July 2004
Phase: Phase 1
Study type: Interventional

The purpose of this pilot study is to investigate the use of minocycline and doxycycline as medical therapy for inoperable or partially treated arteriovenous malformations (AVMs) and giant aneurysms.

NCT ID: NCT00004436 Completed - Hemangioma Clinical Trials

Randomized Study of Hormonal Regulation of Infantile Hemangioma

Start date: July 1993
Phase: N/A
Study type: Interventional

OBJECTIVES: I. Evaluate the clinical efficacy of leuprolide, a gonadotropin-releasing hormone agonist (GnRHa), in treating infants with vision-endangering or large, disfiguring hemangiomas. II. Assess the impact of GnRHa on growth and development during infancy. III. Assess the safety of GnHRa in these patients.

NCT ID: NCT00001417 Completed - Neoplasm Metastasis Clinical Trials

Direct Injection of Alcohol for the Treatment of Spinal Tumors

Start date: June 1994
Phase: N/A
Study type: Observational

Tumors of the spine can be described as primary, meaning that the tumor originated from cells normally found in the spine, or metastatic, cells from another area of the body that have spread to the spine. Metastatic tumors are more common than primary tumors. Tumors of the spine can press against the spinal cord and interfere with information traveling down from the brain to the nerves of the spinal cord. As a result, patients with spinal tumors can suffer from loss of movement and sensation within areas of the body below the tumor. In addition, tumors of the spine are typically painful conditions. Presently, the treatment of choice for spinal tumors is radiation therapy. However, many tumors of the spine become resistant to radiation therapy. In addition, because the spinal cord is often so close to the tumor it can be damaged by the radiation. Absolute (100%) ethanol is commonly known as "alcohol". It is the same kind of alcohol found in alcoholic beverages. When pure alcohol is injected directly into a tumor it can destroy cells and blood vessels. Because of this feature, researchers would like to test the effectiveness of alcohol in treating patients with spinal tumors. Researchers believe that intratumoral ethanol injection is a treatment worth studying more closely because it is minimally invasive, has been proven to be an effective treatment for other types of metastatic tumors, can be used repeatedly, and does not interfere with other treatments such as surgery. In addition to testing the effectiveness of intratumoral ethanol injection, this study will attempt to determine the causes of pain associated with spinal tumors.

NCT ID: NCT00001364 Completed - Clinical trials for Arteriovenous Fistula

Evaluation and Treatment of Patients Spinal Blood Vessel Abnormalities

Start date: June 2, 1993
Phase: N/A
Study type: Observational

Arteriovenous malformations (AVM) are abnormally formed blood vessels that can be located throughout the brain and spinal cord. Patients with abnormalities of the blood vessels located in and around the spinal cord can develop many neurological problems. Some problems include, weakness, pain, difficulty walking, paralysis, and even death. The treatment for these AVMs depends on their location, the type of malformation, the area of the spine involved, and the condition of the patient at the time of treatment. The treatment is aimed at stopping the neurologic problems from worsening and possibly correcting the existing problems. There are two commonly used treatments for AVMs, surgery and embolization (blocking off of blood flow to the AVM). However, researchers have limited experience treating these conditions because they are rare. In addition, it has been difficult to classify different kinds of AVMs and to develop new treatments for them. This study is designed to increase researchers understanding of AVMs by admitting and following patients diagnosed with the condition. By increasing the amount of patients studied diagnosed with spinal blood vessel abnormalities, researchers can begin to develop new management plans for patients with AVMs.